Patrick Treanor - May 26, 2022 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
May 26, 2022
Transactions value $
$0
Form type
3
Date filed
5/27/2022, 04:16 PM
Next filing
Sep 28, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.